Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Intensity of Survivin Expression Correlates with Clinical and Biological Markers of Aggressive R/R DLBCL

Sila Usta, Alexandra Misura, Kim Roos, Iran Rashedi, Irina Amitai, Yidi Jiang, Kathryn Mangoff, Gail Klein, Nicholas Allen Forward, Douglas A. Stewart, Joy Mangel, George A. Tomlinson, Hubert Tsui, Neil Berinstein

Blood (2023) 142 (Supplement 1): 6124.

https://doi.org/10.1182/blood-2023-189200

Published: 2023

Journal Articles

Risk of Major Bleeding with Ibrutinib in Patients with Thrombocytopenia - a Retrospective Single-Center Canadian Study

Mina Dehghani, Taylor Dear, Anthony Quint, Martha L Louzada, Selay Lam, Chai Wye Phua, Joy Mangel, Kang Howson-Jan, Michael J. Kovacs, Alejandro lazo-Langer, Anargyros Xenocostas, Cyrus C. Hsia

Blood (2021) 138 (Supplement 1): 4682.

https://doi.org/10.1182/blood-2021-153719

Published: 2021

Journal Articles

Effect of Levofloxacin Prophylaxis on Rates of Febrile Neutropenia in Patients Receiving DA-EPOCH-R Chemotherapy for Aggressive Lymphomas

Brent Alexander Parker, Mina Dehghani, Selay Lam, Chai Wye Phua, Cheryl Foster, Kang Howson-Jan, Joy Mangel

Blood (2021) 138 (Supplement 1): 4575.

https://doi.org/10.1182/blood-2021-151885

Published: 2021

Journal Articles

Excellent Outcomes in Patients with Primary and Secondary Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using a Rituximab, Busulfan, Melphalan, Thiotepa Conditioning Regimen

Shona Philip, BSc, MD, Adrienne Fulford, NP,MSN, Selay Lam, MDBSc,FRCPC, Chai Wye Phua, MD FRCPC, Joy Mangel, MD FRCPC, Kang Howson-Jan, MD FRCPC, Brandon Dorland, NP, MSN, Karen Atkinson, NP, MSN, Anargyros Xenocostas, MD FRCPC, Uday Deotare, MBBS, MD DM

Blood (2020) 136 (Supplement 1): 2.

https://doi.org/10.1182/blood-2020-139635

Published: 2020

Journal Articles

Clinical Effectiveness of Combination Immunotherapy DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

Neil L Berinstein, MD, Isabelle Bence-Bruckler, MD, Nicholas Allen Forward, MDMSc,FRCPC, Pierre Laneuville, MD FRCPC, Joy Mangel, MD FRCPC, Douglas A. Stewart, MD FRCPC, Irina Amitai, MD, Gail Klein, MSc, Nancy Pennell, BSc, Iran Rashedi, MD MSc, Kim Roos, BA, BSc, Yogesh Bramhecha, Rebekah Conlon, RN

Blood (2020) 136 (Supplement 1): 16.

https://doi.org/10.1182/blood-2020-136751

Published: 2020

Journal Articles

The Use of CEP (Lomustine, Etoposide and Prednisone), an All-Oral Palliative Chemotherapy Regimen, in Aggressive Lymphomas

Lakshman Vasanthamohan, MD FRCPC, Brent Parker, MD, Joy Mangel, MD FRCPC, Selay Lam, MDBSc,FRCPC, Kang Howson-Jan, MD FRCPC, Chai Wye Phua, MD FRCPC

Blood (2019) 134 (Supplement_1): 4131.

https://doi.org/10.1182/blood-2019-126997

Published: 2019

Journal Articles

Safe Start of Ibrutinib in Patients with Chronic Lymphocytic Leukemia and Uncontrolled Autoimmune Hemolytic Anemia

Alejandro Garcia-Horton, MD, Rosanne St. Bernard, MD, Alejandro Lazo-Langner, MD MSc, Anargyros Xenocostas, MD, Joy Mangel, MD FRCPC, Kang Howson-Jan, MD FRCPC, Selay Lam, MDBSc, FRCPC, Cyrus C. Hsia, MDBSc, FRCPC

Blood (2018) 132 (Supplement 1): 5560.

https://doi.org/10.1182/blood-2018-99-120129

Published: 2018

Journal Articles

The Efficacy of PET-CT in Detecting Bone Marrow Involvement in Patients with Newly Diagnosed Lymphoma: A Retrospective Study

Kartiga Thiyagarajah, MD, Olfat Kamel-Hasan, MD, Asmaa Hawsawy, MD, David Laidley, MD FRCPC, Joy Mangel, MD FRCPC

Blood (2017) 130 (Supplement 1): 4160.

https://doi.org/10.1182/blood.V130.Suppl_1.4160.4160

Published: 2017

Journal Articles

Safety and Efficacy of Mini-CHOP-R Chemotherapy for Treatment of Diffuse Large B Cell Lymphoma in Very Elderly Patients: A Quality Assurance Study

Mitchell D.B. Hodgins, MD FRCPC, Joy Mangel, MD FRCPC, Gwynivere Davies, MD FRCPC, Leonard A. Minuk, MD FRCPC, Selay Lam, BSc, MD FRCPC

Blood (2015) 126 (23): 2720.

https://doi.org/10.1182/blood.V126.23.2720.2720

Published: 2015

Journal Articles

Effect of Unintentional Cyclophosphamide Under-Dosing on Disease Response and Outcomes in Patients with Diffuse Large B-Cell Lymphoma

Majed Alahmadi, MBBS, Joy Mangel, MD FRCPC, Ally Dhalla, Kevin Liu, Alejandro Lazo-Langer, MD, Leonard A Minuk, MD FRCPC

Blood (2014) 124 (21): 5441.

https://doi.org/10.1182/blood.V124.21.5441.5441

Published: 2014

Journal Articles

Safety and Efficacy of Dose Attentuated R-CHOP Chemotherapy for Treatment of Diffuse Large B Cell Lymphoma in the Very Elderly: A Cohort Study

Selay Lam, BSc, MD FRCPC, Ian H. Chin-Yee, MD FRCPC, Leonard A Minuk, MD FRCPC, Joy Mangel, MD FRCPC

Blood (2014) 124 (21): 5447.

https://doi.org/10.1182/blood.V124.21.5447.5447

Published: 2014

Journal Articles

The effect of rituximab on vaccine responses in patients with immune thrombocytopenia

Ishac Nazi, John G. Kelton, Mark Larché, Denis P. Snider, Nancy M. Heddle, Mark A. Crowther, Richard J. Cook, Alan T. Tinmouth, Joy Mangel, Donald M. Arnold

Blood (2013) 122 (11): 1946–1953.

https://doi.org/10.1182/blood-2013-04-494096

Published: 2013

Journal Articles

A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies

Laurie H. Sehn, Sarit E. Assouline, Douglas A. Stewart, Joy Mangel, Randy D. Gascoyne, Gregg Fine, Susan Frances-Lasserre, David J. Carlile, Michael Crump

Blood (2012) 119 (22): 5118–5125.

https://doi.org/10.1182/blood-2012-02-408773

Published: 2012

Journal Articles

A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia

Donald M. Arnold, Nancy M. Heddle, Julie Carruthers, Deborah J. Cook, Mark A. Crowther, Ralph M. Meyer, Yang Liu, Richard J. Cook, Anne McLeod, Janet A. MacEachern, Joy Mangel, David Anderson, Linda Vickars, Alan Tinmouth, Andre C. Schuh, John G. Kelton

Blood (2012) 119 (6): 1356–1362.

https://doi.org/10.1182/blood-2011-08-374777

Published: 2012

Journal Articles

Comparison of Conventional Cytology Vs. High Sensitivity Flow Cytometry for the Diagnosis of Leptomeningeal Involvement by Hematological Lymphoid Malignancies

Selay Lam, MD, Ian H. Chin-Yee, MD, FRCPC, Michael Keeney, ART, FIMLS, FCSMLS(D), Janice Popma, Kamilia Rizkalla, MD, FRCPC, Joy Mangel, MD, FRCPC

Blood (2010) 116 (21): 3112.

https://doi.org/10.1182/blood.V116.21.3112.3112

Published: 2010

Journal Articles

Treatment of Hodgkin Lymphoma without G-CSF Does Not Increase the Risk of Febrile Neutropenia.

Leonard A. Minuk, MD, FRCPC, Ian Chin-Yee, MD, FRCPC, Kang Howson-Jan, MD, FRCPC, Reinhard Lohmann, MD, FRCPC, Alejandro Lazo-Langner, MD MSC, Vinai C. Bhagirath, MD, Joy Mangel, MD, FRCPC

Blood (2009) 114 (22): 2502.

https://doi.org/10.1182/blood.V114.22.2502.2502

Published: 2009

Journal Articles

A Phase I Study of GA101 (RO5072759) Monotherapy Followed by Maintenance in Patients with Multiply Relapsed/Refractory CD20 + Malignant Disease.

Laurie H. Sehn, MD, MPH, Sarit E. Assouline, MD, Douglas A. Stewart, MD, Joy Mangel, MD, FRCPC, Pavel Pisa, MD, PhD, Jaimal Kothari, MD, Michael Crump, MD

Blood (2009) 114 (22): 934.

https://doi.org/10.1182/blood.V114.22.934.934

Published: 2009

Journal Articles

Screening for Leptomeningeal Disease by High-Sensitivity Flow Cytometry in High Risk Patients with Aggressive Non-Hodgkin’s Lymphoma.

Joy Mangel, Jazmin Marlinga, Mike Keeney, Jan Popma, Anargyros Xenocostas, Kang Howson-Jan, Kamilia Rizkalla, Ian Chin-Yee

Blood (2007) 110 (11): 4397.

https://doi.org/10.1182/blood.V110.11.4397.4397

Published: 2007

Journal Articles

Autologous Stem-Cell Transplant with a Rituximab Purge and Maintenance vs. Standard Chemotherapy for Mantle Cell Lymphoma: Extended Follow-Up of a Matched Pair Analysis.

Lisa Hicks, Joseph M. Connors, Joy Mangel, Rena Buckstein, Michael Crump, Heather Leitch, Kevin Imrie, Tracy Nagy, Angela Boudreau, Nancy Pennell, David Spaner, Neil Berinstein

Blood (2006) 108 (11): 3051.

https://doi.org/10.1182/blood.V108.11.3051.3051

Published: 2006

Journal Articles

Delays in the Cancer Pathway from Symptom Onset to Initiation of Treatment – A Retrospective Study in Patients with Non-Hodgkin’s Lymphoma.

Reem Nassur, MD, Joy Mangel, MD, Ian Chin-Yee, MD

Blood (2006) 108 (11): 347.

https://doi.org/10.1182/blood.V108.11.347.347

Published: 2006

NARROW

Intensity of Survivin Expression Correlates with Clinical and Biological Markers of Aggressive R/R DLBCL

Risk of Major Bleeding with Ibrutinib in Patients with Thrombocytopenia - a Retrospective Single-Center Canadian Study

Effect of Levofloxacin Prophylaxis on Rates of Febrile Neutropenia in Patients Receiving DA-EPOCH-R Chemotherapy for Aggressive Lymphomas

Excellent Outcomes in Patients with Primary and Secondary Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using a Rituximab, Busulfan, Melphalan, Thiotepa Conditioning Regimen

Clinical Effectiveness of Combination Immunotherapy DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

The Use of CEP (Lomustine, Etoposide and Prednisone), an All-Oral Palliative Chemotherapy Regimen, in Aggressive Lymphomas

Safe Start of Ibrutinib in Patients with Chronic Lymphocytic Leukemia and Uncontrolled Autoimmune Hemolytic Anemia

The Efficacy of PET-CT in Detecting Bone Marrow Involvement in Patients with Newly Diagnosed Lymphoma: A Retrospective Study

Safety and Efficacy of Mini-CHOP-R Chemotherapy for Treatment of Diffuse Large B Cell Lymphoma in Very Elderly Patients: A Quality Assurance Study

Effect of Unintentional Cyclophosphamide Under-Dosing on Disease Response and Outcomes in Patients with Diffuse Large B-Cell Lymphoma

Safety and Efficacy of Dose Attentuated R-CHOP Chemotherapy for Treatment of Diffuse Large B Cell Lymphoma in the Very Elderly: A Cohort Study

The effect of rituximab on vaccine responses in patients with immune thrombocytopenia

A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies

A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia

Comparison of Conventional Cytology Vs. High Sensitivity Flow Cytometry for the Diagnosis of Leptomeningeal Involvement by Hematological Lymphoid Malignancies

Treatment of Hodgkin Lymphoma without G-CSF Does Not Increase the Risk of Febrile Neutropenia.

A Phase I Study of GA101 (RO5072759) Monotherapy Followed by Maintenance in Patients with Multiply Relapsed/Refractory CD20 + Malignant Disease.

Screening for Leptomeningeal Disease by High-Sensitivity Flow Cytometry in High Risk Patients with Aggressive Non-Hodgkin’s Lymphoma.

Autologous Stem-Cell Transplant with a Rituximab Purge and Maintenance vs. Standard Chemotherapy for Mantle Cell Lymphoma: Extended Follow-Up of a Matched Pair Analysis.

Delays in the Cancer Pathway from Symptom Onset to Initiation of Treatment – A Retrospective Study in Patients with Non-Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only